1
项与 Depigoid dust mite vaccine(Laboratorios LETI SL) 相关的临床试验A Multicentre, Open Label, Phase IIb Clinical Trial to Evaluate Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites Mixes at 200 DPP/ml (DP/MG/14-1 Dermatophagoides Pteronyssinus / Lepidoglyphus Destructor and DP/MG/14-2 Dermatophagoides Pteronyssinus /Blomia Tropicalis) in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic Asthma
This is an open-label, non-controlled, non-randomised, prospective safety study in patients with rhinitis or allergic rhinoconjunctivitis, with controlled asthma, and clinically relevant sensitisation to dust mites from the Pyroglyphidae and Glycyphagidae families.
100 项与 Depigoid dust mite vaccine(Laboratorios LETI SL) 相关的临床结果
100 项与 Depigoid dust mite vaccine(Laboratorios LETI SL) 相关的转化医学
100 项与 Depigoid dust mite vaccine(Laboratorios LETI SL) 相关的专利(医药)
100 项与 Depigoid dust mite vaccine(Laboratorios LETI SL) 相关的药物交易